Plasma osteopontin can be classified as a melanoma biomarker, and by combining clinicopathological prognostic variables, the diagnostic effect of blood biomarkers in the detection of metastatic melanoma can be improved. The gene discussed is SPP1; the disease is metastatic melanoma.